| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-12 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.22 | 7e-11 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-09 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.4 | 2e-09 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-08 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-08 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-07 |